Covalent modifications of DNA (DNA adducts, see schematic representation) play a key role in chemical carcinogenesis and are regarded as individual, internal dosimeters for exposure to genotoxic compounds. The analysis of DNA adducts has the potential to become an integral component of risk assessment.
No takes yet. Share an insight, caveat, or question.
Schmitz et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: